Erritzoe et al. (2011) conducted in vivo imaging of cerebral serotonin transporter and serotonin 2A receptor binding in users of 3,4-methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) and other hallucinogens.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (2)

• hallucinogens concept
• serotonin 2A receptor concept